Inventor · disambiguated record
Josephus Johannes De Kimpe
Also filed as: DE KIMPE JOSEPHUS JOHANNES
15 granted patents·19 pending applications·377 citations·filing 2007–2023
94Inventor score
Files withBIOMARIN TECH BV19PROSENSA TECHNOLOGIES BV4DE KIMPE JOSEPHUS JOHANNES3CFM PHARMA HOLDING B V1CFM PHARMA HOLDING BV1
Top patents by PatentIndex Score
34 records- 0198US10533171B2Oligonucleotide comprising an inosine for treating DMDBIOMARIN TECH BV·Filed 2017·Granted Jan 14, 2020·36 cites·12 claims
- 0297USRE48468EMeans and methods for counteracting muscle disordersBIOMARIN TECH BV·Filed 2018·Granted Mar 16, 2021·25 cites·42 claims
- 0397US9926557B2Methods and means for efficient skipping of exon 45 in Duchenne muscular dystrophy pre-mRNADE KIMPE JOSEPHUS JOHANNES·Filed 2011·Granted Mar 27, 2018·50 cites·11 claims
- 0497US9243245B2Means and methods for counteracting muscle disordersDE KIMPE JOSEPHUS JOHANNES·Filed 2010·Granted Jan 26, 2016·76 cites·22 claims
- 0596US9890379B2Treatment of genetic disorders associated with DNA repeat instabilityBIOMARIN TECH BV·Filed 2015·Granted Feb 13, 2018·42 cites·17 claims
- 0696US9528109B2Methods and means for efficient skipping of exon 45 in duchenne muscular dystrophy pre-mRNAPROSENSA TECH B V·Filed 2014·Granted Dec 27, 2016·60 cites·23 claims
- 0794US9139828B2Method for efficient exon (44) skipping in duchenne muscular dystrophy and associated meansPLATENBURG GERARD JOHANNES·Filed 2010·Granted Sep 22, 2015·41 cites·15 claims
- 0893US11034956B2Oligonucleotide comprising an inosine for treating DMDBIOMARIN TECH BV·Filed 2019·Granted Jun 15, 2021·3 cites·10 claims
- 0991US10689646B2Treatment of genetic disorders associated with DNA repeat instabilityBIOMARIN TECH BV·Filed 2017·Granted Jun 23, 2020·4 cites·16 claims
- 1091US8263760B2Methods and means for treating DNA repeat instability associated genetic disordersDE KIMPE JOSEPHUS JOHANNES·Filed 2010·Granted Sep 11, 2012·26 cites·8 claims
- 1186US2024141339A1Oligonucleotide Comprising Inosine for Treating DMDBIOMARIN TECH BV·Filed 2023·Application pending·0 cites
- 1284US2023151362A1Methods and means for efficient dkipping of exon 45 in duchenne muscular dystrophy pre-mrnaBIOMARIN TECH BV·Filed 2022·Application pending·0 cites
- 1383US8802645B2Molecule for treating an inflammatory disorderVAN OMMEN GARRIT-JAN BOUDEWIJN·Filed 2012·Granted Aug 12, 2014·13 cites·23 claims
- 1481US11427820B2Methods and means for efficient skipping of exon 45 in Duchenne muscular dystrophy pre-mRNABIOMARIN TECH BV·Filed 2019·Granted Aug 30, 2022·0 cites·10 claims
- 1579US11634714B2Oligonucleotide comprising an inosine for treating DMDBIOMARIN TECH BV·Filed 2021·Granted Apr 25, 2023·0 cites·9 claims
- 1675US11274299B2Methods and means for treating DNA repeat instability associated genetic disordersBIOMARIN TECH BV·Filed 2019·Granted Mar 15, 2022·0 cites·25 claims
- 1774US10246707B2Method for efficient exon (44) skipping in duchenne muscular dystrophy and associated meansBIOMARIN TECH BV·Filed 2015·Granted Apr 2, 2019·1 cites·12 claims
- 1872US2019112604A1METHODS AND MEANS FOR EFFICIENT SKIPPING OF EXON 45 IN DUCHENNE MUSCULAR DYSTROPHY PRE-mRNABIOMARIN TECH BV·Filed 2018·Application pending·0 cites
- 1972US2019119679A1METHODS AND MEANS FOR EFFICIENT SKIPPING OF EXON 45 IN DUCHENNE MUSCULAR DYSTROPHY PRE-mRNABIOMARIN TECH BV·Filed 2018·Application pending·0 cites
- 2072US2019177725A1METHODS AND MEANS FOR EFFICIENT SKIPPING OF EXON 45 IN DUCHENNE MUSCULAR DYSTROPHY PRE-mRNABIOMARIN TECH BV·Filed 2019·Application pending·0 cites
- 2170US2022267765A1Treatment of genetic disorders associated with dna repeat instabilityVICO THERAPEUTICS B V·Filed 2022·Application pending·0 cites
- 2270US2021207138A1Method for efficient exon (44) skipping in duchenne muscular dystrophy and associated meansBIOMARIN TECH BV·Filed 2020·Application pending·0 cites
- 2368US2014221458A1METHODS AND MEANS FOR EFFICIENT SKIPPING OF EXON 45 IN DUCHENNE MUSCULAR DYSTROPHY PRE-mRNAPROSENSA TECHNOLOGIES BV·Filed 2014·Application pending·0 cites
- 2468US2014113955A1METHODS AND MEANS FOR EFFICIENT SKIPPING OF EXON 45 IN DUCHENNE MUSCULAR DYSTROPHY PRE-mRNAPROSENSA TECHNOLOGIES BV·Filed 2013·Application pending·0 cites
- 2568US2014128592A1METHODS AND MEANS FOR EFFICIENT SKIPPING OF EXON 45 IN DUCHENNE MUSCULAR DYSTROPHY PRE-mRNAPROSENSA TECHNOLOGIES BV·Filed 2013·Application pending·0 cites
- 2666US2017107512A1METHODS AND MEANS FOR EFFICIENT SKIPPING OF EXON 45 IN DUCHENNE MUSCULAR DYSTROPHY PRE-mRNABIOMARIN TECH BV·Filed 2016·Application pending·0 cites
- 2766US2023241078A1Vanadyl and vanadate for use in reducing stress-induced metabolic derangementCFM PHARMA HOLDING B V·Filed 2023·Application pending·0 cites
- 2864US2016304864A1Means and methods for counteracting muscle disordersBIOMARIN TECH BV·Filed 2016·Application pending·0 cites
- 2962US2019292541A1Method for efficient exon (44) skipping in duchenne muscular dystrophy and associated meansBIOMARIN TECH BV·Filed 2019·Application pending·0 cites
- 3061US2016264967A1Oligonucleotide comprising an inosine for treating dmdBIOMARIN TECH BV·Filed 2016·Application pending·0 cites
- 3160US2010184833A1Methods and means for treating dna repeat instability associated genetic disordersPROSENTA TECHNOLOGIES B V·Filed 2007·Application pending·0 cites
- 3257US2015203849A1Oligonucleotide comprising an inosine for treating DMDPROSENSA TECHNOLOGIES BV·Filed 2015·Application pending·0 cites
- 3354US2012046342A1Oligonucleotide comprising an inosine for treating dmdVAN DEUTEKOM JUDITH CHRISTINA THEODORA·Filed 2010·Application pending·0 cites
- 3450US2020246352A1Vanadyl and vanadate for use in reducing stress-induced metabolic derangementCFM PHARMA HOLDING BV·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Josephus Johannes De Kimpe files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →